267 related articles for article (PubMed ID: 33555167)
1. Chronic hepatitis C: a systemic disease.
Mazzaro C
Minerva Med; 2021 Apr; 112(2):159-161. PubMed ID: 33555167
[No Abstract] [Full Text] [Related]
2. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
Cacoub P; Terrier B; Saadoun D
Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
[No Abstract] [Full Text] [Related]
3. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Delluc A; Piette JC; Cacoub P
Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
[TBL] [Abstract][Full Text] [Related]
4. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
Roccatello D; Fenoglio R; Sciascia S
Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
6. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
7. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
9. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
[TBL] [Abstract][Full Text] [Related]
10. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
Degasperi E; Aghemo A; Colombo M
Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
[TBL] [Abstract][Full Text] [Related]
12. B-cells and mixed cryoglobulinemia.
Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
[TBL] [Abstract][Full Text] [Related]
13. Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer.
Visentini M; Quartuccio L; Del Padre M; Colantuono S; Minafò YA; Fiorilli M; De Vita S; Casato M
Rheumatology (Oxford); 2018 Oct; 57(10):1870-1871. PubMed ID: 29868896
[No Abstract] [Full Text] [Related]
14. [Successful rituximab therapy of HCV-cryoglobulinemic vasculitis with severe ulcerative and necrotic lesions of the skin].
Ignatova TM; Chernova OA; Gaĭdasheva EV
Klin Med (Mosk); 2012; 90(5):64-6. PubMed ID: 22993956
[TBL] [Abstract][Full Text] [Related]
15. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
Garini G; Allegri L; Vaglio A; Buzio C
Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
St Clair EW
Arthritis Rheum; 2012 Mar; 64(3):604-8. PubMed ID: 22147537
[No Abstract] [Full Text] [Related]
19. Cryoglobulinemia.
Tedeschi A; Baratè C; Minola E; Morra E
Blood Rev; 2007 Jul; 21(4):183-200. PubMed ID: 17289231
[TBL] [Abstract][Full Text] [Related]
20. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Muro K; Toda N; Yamamoto S; Yanagita M
Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
